Anxiety: 2025 Statistics
Anxiety disorders are the most common mental health condition in the world—but most people never get treated. This guide highlights global and U.S. statistics on who’s affected, how anxiety impacts daily life, and what’s being done to close the care gap and expand access to proven treatments.
Back to Top
Anxiety disorders are a group of the world's most common mental health conditions, characterised by feelings of excessive fear, worry, and distress that become overwhelming and interfere with daily life. Their impact is profound, affecting work, education, and personal relationships.
Globally, an estimated 301 million people were living with an anxiety disorder in 2019, making it the most prevalent mental health condition worldwide. This staggering number underscores a widespread public health issue that, despite being highly treatable, often goes unaddressed due to barriers like stigma and lack of access to care.
- Overall Prevalence and General Numbers
- Breakdown by Key Demographics
- Co-occurrence and Related Conditions
- The Most Serious Consequences
- The Positive Outlook and Solutions
- Conclusion
- Sources
Overall Prevalence and General Numbers
- Global Prevalence: An estimated 4% of the global population experienced an anxiety disorder in 2019.
- COVID-19 Pandemic Impact: The pandemic led to a staggering 27.9% increase in cases of anxiety disorders globally in 2020 alone.
- Prevalence in the US: In the United States, an estimated 19.1% of adults have had an anxiety disorder in the past year, a significantly higher rate than the global average.
- Leading Cause of Disability: Anxiety disorders are a leading cause of disability worldwide. In 2020, they became the third leading cause of Years Lived with Disability (YLDs) globally.
Breakdown by Key Demographics
- By Gender:
- Globally, more women are affected by anxiety disorders than men.
- In the US, the past-year prevalence for adult females was 23.4%, compared to 14.3% for adult males.
- Among US adolescents, the lifetime prevalence was 38.0% for females and 26.1% for males.
- By Age Group (US Data):
- Symptoms often begin in childhood or adolescence. The lifetime prevalence for US adolescents (ages 13-18) is 31.9%.
- Past-year prevalence among US adults peaks in the 30-44 age group (22.7%) and is lowest in adults aged 60 and over (9.0%).
Co-occurrence and Related Conditions
- Co-morbidity: Anxiety disorders significantly increase the risk for developing other conditions, particularly depression and substance use disorders.
- Physical Health Link: The connection to physical health is bidirectional. Chronic anxiety can be a risk factor for cardiovascular disease, while people with other chronic illnesses often experience heightened anxiety.
- Key Risk Factors: Anxiety disorders result from a complex interaction of factors, including:
- Adverse life experiences (abuse, severe loss)
- Genetic predispositions and brain chemistry
- Chronic stress
The Most Serious Consequences
- Disability and Daily Functioning: As a leading cause of disability worldwide, anxiety disorders significantly interfere with job performance, school work, and relationships.
- Suicidal Thoughts and Behaviours: The presence of an anxiety disorder is associated with an increased risk of suicidal thoughts and behaviours.
- Impairment in Youth: Of US adolescents with an anxiety disorder, an estimated 8.3% experience severe impairment as a result of their condition.
The Positive Outlook and Solutions
- Effective Treatment Exists: Psychological interventions like Cognitive Behavioural Therapy (CBT) and certain medications are proven to be highly effective in treating anxiety disorders.
- The Global Treatment Gap: A significant barrier is access to care. Globally, only about 1 in 4 people (27.6%) with an anxiety disorder receive any form of treatment.
- Prevention Strategies: Community-based prevention is effective. Programmes focused on parental education and social-emotional learning in schools can help prevent anxiety in children and adolescents.
- Global Action: The World Health Organisation is actively working to improve access to care through initiatives like the Comprehensive Mental Health Action Plan and the mhGAP Programme.
Conclusion
Anxiety disorders are the most common mental health condition globally, affecting hundreds of millions of people and representing a leading cause of disability. Despite the existence of effective treatments, a staggering treatment gap persists, with the vast majority of people receiving no care. Closing this gap through increased investment, awareness, and prevention is essential for improving public health and well-being worldwide.
Sources
- World Health Organisation (WHO). (2023). Anxiety disorders.
- National Institute of Mental Health (NIMH). (Data 2001-2004). Any Anxiety Disorder.
- Anxiety & Depression Association of America (ADAA). (Data 2001-2003). Facts & Statistics.
- Santomaura, D. F., et al. (2021). Global prevalence and burden of depressive and anxiety disorders in 204 countries and territories in 2020 due to the COVID-19 pandemic. The Lancet.
- Centers for Disease Control and Prevention (CDC). (2024). FastStats - Mental Health.
Important:
TherapyRoute does not provide medical advice. All content is for informational purposes and cannot replace consulting a healthcare professional. If you face an emergency, please contact a local emergency service. For immediate emotional support, consider contacting a local helpline.
Find a Therapist
Find skilled psychologists, psychiatrists, and counsellors near you.
